We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 10,000 results
  1. Azithromycin for Other Lung Diseases: Lung Transplantation and Sarcoidosis

    Azithromycin was introduced in lung transplantation in an attempt to improve the pulmonary function in patients with chronic allograft dysfunction...
    Geert M. Verleden, Stijn E. Verleden in Macrolides as Immunomodulatory Agents
    Chapter 2024
  2. Lung organoids: current strategies for generation and transplantation

    Lung diseases occupy a leading position in human morbidity and are the third leading cause of death. Often the chronic forms of these diseases do not...

    Anna Demchenko, Alexander Lavrov, Svetlana Smirnikhina in Cell and Tissue Research
    Article 30 September 2022
  3. Lung Transplantation under a Janus Kinase Inhibitor in Three Patients with SAVI Syndrome

    Stimulator of interferon genes (STING)-associated vasculopathy with onset in infancy (SAVI) is a very rare autoinflammatory disease related to STING1 ...

    Kenza Rhzioual Berrada, Alexandre Belot, ... Philippe Reix in Journal of Clinical Immunology
    Article 10 October 2023
  4. α7nAChR Activation Combined with Endothelial Progenitor Cell Transplantation Attenuates Lung Injury in Diabetic Rats with Sepsis through the NF-κB Pathway

    Chronic diabetes mellitus compromises the vascular system, which causes organ injury, including in the lung. Due to the strong compensatory ability...

    **aoyun Zhang, Haixu Wang, ... Wengang Ding in Inflammation
    Article 01 February 2024
  5. Exploratory associations of tacrolimus exposure and clinical outcomes after lung transplantation: A retrospective, single center experience

    Purpose

    This study aimed to investigate the potential impact of tacrolimus (TAC) exposure on clinical outcomes after lung transplantation.

    ...
    Wenwen Du, **aoxing Wang, ... **anbo Zuo in European Journal of Clinical Pharmacology
    Article 16 February 2024
  6. Pathobiological signatures of dysbiotic lung injury in pediatric patients undergoing stem cell transplantation

    Hematopoietic cell transplantation (HCT) uses cytotoxic chemotherapy and/or radiation followed by intravenous infusion of stem cells to cure...

    Matt S. Zinter, Christopher C. Dvorak, ... Joseph L. DeRisi in Nature Medicine
    Article Open access 23 May 2024
  7. On Target: An Intrapulmonary Transplantation Method for Modelling Lung Tumor Development in its Native Microenvironment

    The development of in vivo lung cancer models that faithfully mimic the human disease is a crucial research tool for understanding the molecular...
    Jackson A. McDonald, Leanne Scott, ... Kate D. Sutherland in Inflammation and Cancer
    Protocol 2023
  8. Assessment of NLRP3 inflammasome activation in patients with chronic obstructive pulmonary disease before and after lung transplantation

    The interplay between purinergic receptors as well as pattern recognition receptors like Toll-like receptors (TLRs) and NOD-, LRR-, and pyrin...

    Lada Rumora, Ivona Markelić, ... Andrea Vukić Dugac in Immunologic Research
    Article Open access 29 May 2024
  9. Immunosuppression in Lung Transplantation

    Immunosuppression in lung transplantation is an area devoid of robust clinical data. This chapter will review the history of immunosuppression in...
    Joelle Nelson, Elisabeth Kincaide, ... Deborah Jo Levine in Pharmacology of Immunosuppression
    Chapter 2021
  10. Metagenomic sequencing reveals time, host, and body compartment-specific viral dynamics after lung transplantation

    Background

    The virome of lung transplant recipients (LTRs) under immunosuppressive therapy is dominated by non-pathogenic Anelloviridae and further...

    Stefanie Widder, Irene Görzer, ... Elisabeth Puchhammer-Stöckl in Microbiome
    Article Open access 23 April 2022
  11. Association between time in therapeutic range of tacrolimus blood concentration and acute rejection within the first three months after lung transplantation

    Background

    Tacrolimus is a key drug in immunosuppressive therapy following lung transplantation. The blood tacrolimus levels are likely to fluctuate...

    Yoshiki Katada, Shunsaku Nakagawa, ... Tomohiro Terada in Journal of Pharmaceutical Health Care and Sciences
    Article Open access 01 October 2022
  12. HLA in Transplantation

    This chapter is about kidney and bone marrow transplantation, a therapy that is routinely used in our hospitals to correct a failure of different...
    Chapter 2024
  13. Acellular ex vivo lung perfusate silences pro-inflammatory signaling in human lung endothelial and epithelial cells

    Background

    Ischemia–reperfusion injury is a key complication following lung transplantation. The clinical application of ex vivo lung perfusion (EVLP)...

    Jamie E. Jeon, Lei Huang, ... Mingyao Liu in Journal of Translational Medicine
    Article Open access 17 October 2023
  14. Immunology of Transplantation and Malignancy

    Successful transplantation requires a multitude of important steps: surgical asepsis, development of surgical techniques of vascular anastomosis,...
    Subhash Chandra Parija in Textbook of Microbiology and Immunology
    Chapter 2023
  15. Monoclonal Antibodies in Solid Organ Transplantation

    In an attempt to target solid organ transplant immunosuppression, monoclonal antibodies directed against key steps in specific immunologic pathways...
    Nicole A. Pilch, Holly B. Meadows, Rita R. Alloway in Pharmaceutical Biotechnology
    Chapter 2024
  16. Predominantly defective CD8+ T cell immunity to SARS-CoV-2 mRNA vaccination in lung transplant recipients

    Background

    Although mRNA vaccines have overall efficacy preventing morbidity/mortality from SARS-CoV-2 infection, immunocompromised persons remain at...

    Ellie Taus, Michael Y. Shino, ... Otto O. Yang in Journal of Translational Medicine
    Article Open access 08 June 2023
  17. Intact lung tissue and bronchoalveolar lavage fluid are both suitable for the evaluation of murine lung microbiome in acute lung injury

    Background

    Accumulating clinical evidence suggests that lung microbiome is closely linked to the progression of pulmonary diseases; however, it is...

    Lijun Zheng, Chengjun Liu, ... Zhen Zou in Microbiome
    Article Open access 18 March 2024
  18. Dual-color FISH analyses of xenogeneic human fibroblast sheets transplanted to repair lung pleural defects in an immunocompromised rat model

    Background

    Pulmonary air leaks (PALs) due to visceral pleura injury during surgery is frequently observed after pulmonary resections and the...

    Masato Kanzaki, Ryo Takagi, ... Masayuki Yamato in BMC Research Notes
    Article Open access 15 May 2024
  19. Synbiotics in Lung Cancer

    Human microbiota has gained significant interest in the prevention and treatment of cancer. Synbiotics are profound examples of how microbiota can be...
    Diwahar Prakash, Suresh Krishna Venkataramanan, ... Senthil Visaga Ambi in Synbiotics for the Management of Cancer
    Chapter 2023
  20. A case of successful contribution of therapeutic drug monitoring of valganciclovir as the prophylaxis against cytomegalovirus infection in a lung transplant recipient

    Background

    Ganciclovir and its prodrug, valganciclovir, are first-line agents for cytomegalovirus infection prophylaxis after lung transplantation....

    Yoshiki Katada, Keisuke Umemura, ... Tomohiro Terada in Journal of Pharmaceutical Health Care and Sciences
    Article Open access 07 June 2024
Did you find what you were looking for? Share feedback.